These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24062787)

  • 21. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
    Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
    Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
    Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
    Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polydeoxyribonucleotide ameliorates lipopolysaccharide-induced acute lung injury via modulation of the MAPK/NF-κB signaling pathway in rats.
    Ko IG; Hwang JJ; Chang BS; Kim SH; Jin JJ; Hwang L; Kim CJ; Choi CW
    Int Immunopharmacol; 2020 Jun; 83():106444. PubMed ID: 32234670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asatone Prevents Acute Lung Injury by Reducing Expressions of NF-[Formula: see text]B, MAPK and Inflammatory Cytokines.
    Chang HY; Chen YC; Lin JG; Lin IH; Huang HF; Yeh CC; Chen JJ; Huang GJ
    Am J Chin Med; 2018; 46(3):651-671. PubMed ID: 29595073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
    Pei X; Zhang XJ; Chen HM
    Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
    Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
    Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
    Yang H; Lv H; Li H; Ci X; Peng L
    Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-κB and activation Nrf2 pathway.
    Zhang LM; Zhang J; Zhang Y; Wang L; Fei C; Yi ZW; Dong L
    Biochem Biophys Res Commun; 2018 Nov; 505(3):837-842. PubMed ID: 30301527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats.
    Tsai CL; Lin YC; Wang HM; Chou TC
    J Ethnopharmacol; 2014 Apr; 153(1):197-206. PubMed ID: 24534526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
    Lu Y; Yu T; Liu J; Gu L
    PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressed nuclear factor-kappa B alleviates lipopolysaccharide-induced acute lung injury through downregulation of CXCR4 mediated by microRNA-194.
    Chen R; Xie F; Zhao J; Yue B
    Respir Res; 2020 Jun; 21(1):144. PubMed ID: 32522221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
    Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
    Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation.
    Liu H; Lin Z; Ma Y
    Biomed Pharmacother; 2020 May; 125():109943. PubMed ID: 32106380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salviplenoid A from Salvia plebeia attenuates acute lung inflammation via modulating NF-κB and Nrf2 signaling pathways.
    Huang JL; Fan RZ; Zou YH; Zhang L; Yin S; Tang GH
    Phytother Res; 2021 Mar; 35(3):1559-1571. PubMed ID: 33098234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
    Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
    Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Inflammatory Effects of
    Choi Y; Kim MH; Jung DH; Yang WM
    Evid Based Complement Alternat Med; 2021; 2021():6641689. PubMed ID: 33628305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis.
    Lv H; Liu Q; Wen Z; Feng H; Deng X; Ci X
    Redox Biol; 2017 Aug; 12():311-324. PubMed ID: 28285192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis.
    Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
    Int Immunopharmacol; 2021 Jan; 90():107187. PubMed ID: 33249045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tomentosin Inhibits Lipopolysaccharide-Induced Acute Lung Injury and Inflammatory Response by Suppression of the NF-κB Pathway in a Mouse Model of Sepsis.
    Zhu H; Wang Y; Sun J; Fan C; Wan J
    J Environ Pathol Toxicol Oncol; 2020; 39(4):291-298. PubMed ID: 33389901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.